Treatment of hyperfunctional lines of the face with Botulinum toxin A

William J. Binder; Andrew Blitzer; Mitchell F. Brin

doi:10.1111/j.1524-4725.1998.tb04098.x

Treatment of hyperfunctional lines of the face with Botulinum toxin A

William J. Binder
, Andrew Blitzer
, Mitchell F. Brin

Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Article › peer-review

90 Scopus citations

Abstract

Since Botulinum toxin A became a mainstay therapy for blepharospasm, its use in treating other dystonic conditions, spasticity disorders, as well as hyperfunctional lines of the face has increased exponentially in recent years. The following article summarizes our experience in establishing a safe and reliable method of administration of botulinum toxin A for treating hyperfunctional lines of the face.

Original language	English
Pages (from-to)	1198-1205
Number of pages	8
Journal	Dermatologic Surgery
Volume	24
Issue number	11
DOIs	https://doi.org/10.1111/j.1524-4725.1998.tb04098.x
State	Published - Nov 1998

Access to Document

10.1111/j.1524-4725.1998.tb04098.x

Cite this

@article{5ec6fed6f5cc45c09369500f3ff242af,

title = "Treatment of hyperfunctional lines of the face with Botulinum toxin A",

abstract = "Since Botulinum toxin A became a mainstay therapy for blepharospasm, its use in treating other dystonic conditions, spasticity disorders, as well as hyperfunctional lines of the face has increased exponentially in recent years. The following article summarizes our experience in establishing a safe and reliable method of administration of botulinum toxin A for treating hyperfunctional lines of the face.",

author = "Binder, \{William J.\} and Andrew Blitzer and Brin, \{Mitchell F.\}",

year = "1998",

month = nov,

doi = "10.1111/j.1524-4725.1998.tb04098.x",

language = "English",

volume = "24",

pages = "1198--1205",

journal = "Dermatologic Surgery",

issn = "1076-0512",

publisher = "Lippincott Williams and Wilkins",

number = "11",

}

TY - JOUR

T1 - Treatment of hyperfunctional lines of the face with Botulinum toxin A

AU - Binder, William J.

AU - Blitzer, Andrew

AU - Brin, Mitchell F.

PY - 1998/11

Y1 - 1998/11

N2 - Since Botulinum toxin A became a mainstay therapy for blepharospasm, its use in treating other dystonic conditions, spasticity disorders, as well as hyperfunctional lines of the face has increased exponentially in recent years. The following article summarizes our experience in establishing a safe and reliable method of administration of botulinum toxin A for treating hyperfunctional lines of the face.

AB - Since Botulinum toxin A became a mainstay therapy for blepharospasm, its use in treating other dystonic conditions, spasticity disorders, as well as hyperfunctional lines of the face has increased exponentially in recent years. The following article summarizes our experience in establishing a safe and reliable method of administration of botulinum toxin A for treating hyperfunctional lines of the face.

UR - https://www.scopus.com/pages/publications/0031724963

U2 - 10.1111/j.1524-4725.1998.tb04098.x

DO - 10.1111/j.1524-4725.1998.tb04098.x

M3 - Article

C2 - 9834739

AN - SCOPUS:0031724963

SN - 1076-0512

VL - 24

SP - 1198

EP - 1205

JO - Dermatologic Surgery

JF - Dermatologic Surgery

IS - 11

ER -

Treatment of hyperfunctional lines of the face with Botulinum toxin A

Abstract

Access to Document

Fingerprint

Cite this